Low-molecular-weight	low-molecular-weight	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
the	the	O	O	O	O
treatment	treatment	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
mechanical	mechanical	O	O	O	O
heart	heart	O	O	O	O
valves	valves	O	O	O	O
.	.	O	O	O	O

BACKGROUND	background	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
interruption	interruption	O	O	O	O
of	of	O	O	O	O
oral	oral	O	O	O	O
anticoagulant	anticoagulant	O	O	O	O
(	(	O	O	O	O
OAC	oac	O	O	O	O
)	)	O	O	O	O
administration	administration	O	O	O	O
is	is	O	O	O	O
sometimes	sometimes	O	O	O	O
indicated	indicated	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
mechanical	mechanical	O	O	O	O
heart	heart	O	O	O	O
valves	valves	O	O	O	O
,	,	O	O	O	O
mainly	mainly	O	O	O	O
before	before	O	O	O	O
noncardiac	noncardiac	O	O	O	O
surgery	surgery	O	O	O	O
,	,	O	O	O	O
non-surgical	non-surgical	O	O	O	O
interventions	interventions	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
pregnancy	pregnancy	O	O	O	O
.	.	O	O	O	O

Unfractionated	unfractionated	O	O	OTHERS	I
heparin	heparin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
UH	uh	O	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
currently	currently	O	O	O	O
the	the	O	O	O	O
substitute	substitute	O	O	O	O
for	for	O	O	O	O
selected	selected	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Low-molecular-weight	low-molecular-weight	O	O	O	O
heparin	heparin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
LMWH	lmwh	O	O	OTHERS	I
)	)	O	O	O	O
offers	offers	O	O	O	O
theoretical	theoretical	O	O	O	O
advantages	advantages	O	O	O	O
over	over	O	O	O	O
UH	uh	O	O	OTHERS	I
,	,	O	O	O	O
but	but	O	O	O	O
is	is	O	O	O	O
not	not	O	O	O	O
currently	currently	O	O	O	O
considered	considered	O	O	O	O
in	in	O	O	O	O
clinical	clinical	O	O	O	O
guidelines	guidelines	O	O	O	O
as	as	O	O	O	O
an	an	O	O	O	O
alternative	alternative	O	O	O	O
to	to	O	O	O	O
UH	uh	O	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
prosthetic	prosthetic	O	O	O	O
valves	valves	O	O	O	O
.	.	O	O	O	O

HYPOTHESIS	hypothesis	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
aim	aim	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
present	present	O	O	O	O
study	study	O	O	O	O
was	was	O	O	O	O
to	to	O	O	O	O
review	review	O	O	O	O
the	the	O	O	O	O
data	data	O	O	O	O
accumulated	accumulated	O	O	O	O
so	so	O	O	O	O
far	far	O	O	O	O
on	on	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
LMWH	lmwh	O	O	OTHERS	I
in	in	O	O	O	O
this	this	O	O	O	O
patient	patient	O	O	O	O
population	population	O	O	O	O
and	and	O	O	O	O
to	to	O	O	O	O
discuss	discuss	O	O	O	O
its	its	O	O	O	O
applicability	applicability	O	O	O	O
in	in	O	O	O	O
common	common	O	O	O	O
practice	practice	O	O	O	O
.	.	O	O	O	O

METHODS	methods	O	O	O	O
:	:	O	O	O	O
For	for	O	O	O	O
this	this	O	O	O	O
paper	paper	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
current	current	O	O	O	O
medical	medical	O	O	O	O
literature	literature	O	O	O	O
on	on	O	O	O	O
LMWH	lmwh	O	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
mechanical	mechanical	O	O	O	O
heart	heart	O	O	O	O
valves	valves	O	O	O	O
was	was	O	O	O	O
extensively	extensively	O	O	O	O
reviewed	reviewed	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
There	there	O	O	O	O
were	were	O	O	O	O
eight	eight	O	O	O	O
series	series	O	O	O	O
and	and	O	O	O	O
six	six	O	O	O	O
case	case	O	O	O	O
reports	reports	O	O	O	O
.	.	O	O	O	O

None	none	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
studies	studies	O	O	O	O
was	was	O	O	O	O
randomized	randomized	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
only	only	O	O	O	O
one	one	O	O	O	O
was	was	O	O	O	O
prospective	prospective	O	O	O	O
.	.	O	O	O	O

Data	data	O	O	O	O
to	to	O	O	O	O
establish	establish	O	O	O	O
the	the	O	O	O	O
thromboembolic	thromboembolic	O	DISEASE	OTHERS	I
risk	risk	O	O	O	O
were	were	O	O	O	O
incomplete	incomplete	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
excluding	excluding	O	O	O	O
case	case	O	O	O	O
reports	reports	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
following	following	O	O	O	O
groups	groups	O	O	O	O
were	were	O	O	O	O
constructed	constructed	O	O	O	O
:	:	O	O	O	O
(	(	O	O	O	O
a	a	O	O	O	O
)	)	O	O	O	O
short-term	short-term	O	O	O	O
administration	administration	O	O	O	O
,	,	O	O	O	O
after	after	O	O	O	O
valve	valve	O	O	O	O
insertion	insertion	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
212	212	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
(	(	O	O	O	O
b	b	O	O	O	O
)	)	O	O	O	O
short-term	short-term	O	O	O	O
,	,	O	O	O	O
perioperative	perioperative	O	O	O	O
(noncardiac)/periprocedural	(noncardiac)/periprocedural	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
114	114	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
(	(	O	O	O	O
c	c	O	O	OTHERS	I
)	)	O	O	O	O
long-term	long-term	O	O	O	O
,	,	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
intolerance	intolerance	O	O	O	O
to	to	O	O	O	O
OAC	oac	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
16	16	O	O	O	O
)	)	O	O	O	O
;	;	O	O	O	O
(	(	O	O	O	O
d	d	O	O	O	O
)	)	O	O	O	O
long-term	long-term	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
pregnancy	pregnancy	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
10	10	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
incidence	incidence	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
thromboembolism	thromboembolism	O	O	OTHERS	I
was	was	O	O	O	O
0.9	0.9	O	O	O	O
%	%	O	O	O	O
for	for	O	O	O	O
all	all	O	O	O	O
the	the	O	O	O	O
studies	studies	O	O	O	O
and	and	O	O	O	O
0.5	0.5	O	O	O	O
,	,	O	O	O	O
0	0	O	O	O	O
,	,	O	O	O	O
20	20	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
0	0	O	O	O	O
%	%	O	O	O	O
in	in	O	O	O	O
groups	groups	O	O	O	O
a	a	O	O	O	O
,	,	O	O	O	O
b	b	O	O	O	O
,	,	O	O	O	O
c	c	O	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
d	d	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
;	;	O	O	O	O
for	for	O	O	O	O
hemorrhage	hemorrhage	O	DISEASE	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
overall	overall	O	O	O	O
rate	rate	O	O	O	O
was	was	O	O	O	O
3.4	3.4	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
3.8	3.8	O	O	O	O
,	,	O	O	O	O
2.6	2.6	O	O	O	O
,	,	O	O	O	O
10	10	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
0	0	O	O	O	O
%	%	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
respective	respective	O	O	O	O
groups	groups	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
In	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
mechanical	mechanical	O	O	O	O
heart	heart	O	O	O	O
valves	valves	O	O	O	O
,	,	O	O	O	O
short-term	short-term	O	O	O	O
LMWH	lmwh	O	O	OTHERS	I
therapy	therapy	O	O	O	O
compares	compares	O	O	O	O
favorably	favorably	O	O	O	O
with	with	O	O	O	O
UH	uh	O	O	OTHERS	I
.	.	O	O	O	O

Data	data	O	O	O	O
on	on	O	O	O	O
mid-	mid-	O	O	O	O
and	and	O	O	O	O
long-term	long-term	O	O	O	O
LMWH	lmwh	O	O	OTHERS	I
administration	administration	O	O	O	O
in	in	O	O	O	O
these	these	O	O	O	O
patients	patients	O	O	O	O
are	are	O	O	O	O
sparse	sparse	O	O	O	O
.	.	O	O	O	O

Further	further	O	O	O	O
randomized	randomized	O	O	O	O
studies	studies	O	O	O	O
are	are	O	O	O	O
needed	needed	O	O	O	O
to	to	O	O	O	O
confirm	confirm	O	O	O	O
the	the	O	O	O	O
safety	safety	O	O	O	O
and	and	O	O	O	O
precise	precise	O	O	O	O
indications	indications	O	O	O	O
for	for	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
LMWH	lmwh	O	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
mechanical	mechanical	O	O	O	O
heart	heart	O	O	O	O
valves	valves	O	O	O	O
.	.	O	O	O	O

